Eli Lilly's price cut, Thanksgiving box office and more: Morning Squawk

In today's market update, investors are greeted with notable developments as we dive into the trading day. Last week's market momentum saw both the Dow Jones Industrial Average and the S&P 500 notch their seventh consecutive month of gains. However, tech stocks faced challenges as concerns about excessive investments in artificial intelligence lingered. In a significant move, Eli Lilly has announced a reduction in the monthly cash price of its weight-loss medication, Zepbound, available on its direct-to-consumer platform. Patients with a valid prescription can now purchase the drug for between $299 and $449, a decrease from the previous range of $349 to $499. This decision follows recent agreements signed by President Trump with both Eli Lilly and Novo Nordisk aimed at enhancing the affordability and accessibility of popular weight-loss treatments. On the entertainment front, this year's Thanksgiving box office is shaping up to be one for the record books. Early estimates indicate that the holiday weekend could generate around $294 million, with final numbers expected to be released soon. Notably, Disney's "Zootopia 2" has emerged as a box office leader, raking in approximately $156 million. Additionally, IMAX reported a remarkable $40.8 million in global ticket sales over the five-day period, marking a new all-time high and a staggering 70% increase from last year. In the aviation sector, European shares of Airbus took a hit following news of an industrial quality issue affecting a number of its A320-family aircraft. Reports suggest a flaw in the fuselage panels has led to delivery delays, although there are no current impacts on aircraft already in operation. Airbus has yet to provide comments regarding these developments. Furthermore, family-run businesses specializing in personalized memorial products are grappling with challenges stemming from increasing cremation rates and new tariffs imposed by the Trump administration. Despite these hurdles, many continue to import granite from overseas due to higher domestic labor costs and the limited availability of certain stone types in the U.S. As John Dioguardi from Rome Monument noted, "God gave the different parts of the world certain yummies." Stay tuned for more updates as we continue to monitor key market trends and events throughout the week.